Change Please Brings Coffee with a Cause to Fitzsimons Innovation Community

By: Fitzsimons Innovation Community Here on the Fitzsimons Innovation Community campus, life sciences professionals thrive on collaboration, innovation, and breakthroughs in patient care. Another thin...

Learn More

Colorado’s Life Sciences Ecosystem is Strengthened by Competitive, Pro-Innovation Mergers & Acquisitions 

In October 2023, CBSA partnered with more than thirty leading organizations to launch the Partnership for the U.S. Life Science Ecosystem (PULSE), a coalition working to raise awareness of the fundame...

Learn More

Weekly Policy Blog: CBSA PAC Fuels Policy + Advocacy Engagement and Impact 

CBSA’s Policy + Advocacy team works year-round to represent Colorado’s life sciences ecosystem at the State Capitol. The bipartisan Colorado BioScience Political Action Committee (CBSA PAC) is a criti...

Learn More

Colorado BioScience Association Announces Finalists to be Honored 21st Annual Awards Celebration, Presented by AGC Biologics

NEWS RELEASE For Immediate Release: October 16, 2024 Colorado BioScience Association Announces Finalists to be Honored 21st Annual Awards Celebration, Presented by AGC Biologics Edgewise Therapeutics...

Learn More

Weekly Policy Blog: Updates on IP Protections 

CBSA advocates for policies that sustain innovation and create high-wage, high value jobs in life sciences, including strong intellectual property (IP) protections, which are the foundation of technol...

Learn More

Strategic Life Sciences Partnerships Find a New Altitude

The mountains are calling at the 2024 Colorado BioScience Association Rocky Mountain Life Sciences Investor & Partnering Conference. By: Fitzsimons Innovation Community For the past 15 years, Elys...

Learn More

Weekly Policy Blog: Watching Congress: PPRV Program Reauthorization and the “Breakthrough Act” 

Congress is grappling with a busy and complex agenda before adjourning on September 27 through the election. Congress is on track to meet its deadline of October 1 to pass a government funding measure...

Learn More

Weekly Policy Blog: Industry Lawsuits Challenge the IRA’s Medicare Drug Price Negotiation Program 

The newly-announced “negotiated” prices for the first ten drugs subject to price controls under the Inflation Reduction Act (IRA) are set to go into effect for people with Medicare Part D prescription...

Learn More

Weekly Policy Blog: CMS Announces MFPs for First Set of Drugs Subject to Price Controls Under the IRA 

On August 15, 2024, the Centers for Medicare & Medicaid Services (CMS) announced the new “negotiated” prices for the first ten Medicare Part D drugs subject to price controls under the Inflation R...

Learn More

Fitzsimons Innovation Community and the CU Innovations Program

A partnership building bright futures. By: Fitzsimons Innovation Community In almost every sentence where Fitzsimons Innovation Community is mentioned, so too is our proximity to and partnership with...

Learn More